BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2002
View Archived Issues
LY-451395 enters the brain following multiple oral doses in man
Read More
Favorable pharmacokinetic profile described for new camptothecin analogue DRF-1042
Read More
Escalating oral and i.v. doses of sabiporide tested in humans for safety and PK/PD profile
Read More
New data on natalizumab presented at ACTRI/ECTRI conference
Read More
Zenapax may improve the therapeutic effect of interferon in multiple sclerosis
Read More
Quetiapine found to improve cognitive function in first-episode psychosis
Read More
No antiplatelet effects found for a supratherapeutic dose of valdecoxib in healthy subjects
Read More
Potential reported for RWJ-67657 in the management of sepsis and cytokine-mediated disorders
Read More
Acyline is safe and decreases serum gonadotropin and testosterone levels in humans
Read More
New data on the antiangiogenic effects of endostatin against advanced solid tumors
Read More
Cilomilast proven effective in improving lung function of smoking and nonsmoking COPD patients
Read More
Beneficial effects on chronic lung rejection reported for switching from ciclosporin to tacrolimus
Read More
Cozaar reduces the risk of ESRD in patients with type 2 diabetes, nephropathy and hypertension
Read More
Global collaboration signed for potential breakthrough diabetes therapy
Read More
Genmab's HuMax-CD4 enters phase IIb trial in psoriasis
Read More
Endovasc spin-off company will develop Liprostin
Read More
Access Oncology obtains rights to develop and market antitumor alkylphosphocholine
Read More
Hybridon and Aegera collaborate to develop antisense drug targeting XIAP gene
Read More
5-HT6 ligands claimed in the patent literature by Wyeth
Read More
Urotensin-II receptor antagonists and potential uses described in recent patent
Read More
Novel CRF1 antagonists identified at Bristol-Myers Squibb
Read More
Synthesis, activity and use of glycine uptake inhibitors reported
Read More
Recent patent covers new human PPAR activators discovered at GSK
Read More
GSK designs new series of antiangiogenic agents
Read More